Diane – US: HIV, Fibromyalgia, CFS/ME (LDN, low dose naltrexone)

Diane – US: HIV, Fibromyalgia, CFS/ME (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Linda Elsegood: Diane from the United States. You take LDN for fibromyalgia, chronic fatigue syndrome, and Diane has been HIV positive for 26 years. Thank you for joining me, Diane. Diane: You’re welcome. My pleasure. Linda Elsegood: Could you […]

The Use of Naltrexone in Low Doses Beyond the Approved Indication… (News)

The Use of Naltrexone in Low Doses Beyond the Approved Indication [Internet] Report from Norwegian Knowledge Centre for the Health Services April 2015 https://pubmed.ncbi.nlm.nih.gov/28510411/ In Norway, naltrexone is approved as supportive treatment of alcohol dependence. The recommended dose is 50 mg, equivalent to the marketed tablet. Naltrexone in much lower doses than 50 mg has […]

Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion (Abstract)

Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion Cureus 10 July 2018 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126779/ Low dose naltrexone (LDN) has been promising as a complementary medication for patients with a broad range of medical disorders. Although not a proven cure, evidence from clinical trials supports LDN as being a valuable adjunct for disorders in […]

Could Low-Dose Naltrexone be an Effective Treatment for Hailey-Hailey Disease? (Abstract)

Could Low-Dose Naltrexone be an Effective Treatment for Hailey-Hailey Disease? Integ Biomed Sci 19 July 2016 https://www.gratisoa.org/journals/index.php/MML/article/view/1293/957 These data and patient testimonials suggest that LDN may be an effective treatment for HHD. However, many physicians hesitate to prescribe LDN because of the lack of published studies. The severity of complications from HHD is understated. Thus […]

Bernard Bihari, MD: Low-Dose Naltrexone for normalizing immune system function (Abstract)

Bernard Bihari, MD: Low-Dose Naltrexone for normalizing immune system function Altern Ther Health Med 05 November 2013 https://todayspractitioner.com/wp-content/uploads/2013/10/Bernard-Bihari-MD-Low-dose-Naltrexone-for-Normalizing-Immune-System-Function-athm_19_2_bihari_56_65.pdf Bernard Bihari, MD, (1931-2010) was the discoverer of the clinical effects of low-dose naltrexone (LDN) in humans. In his groundbreaking clinical trial of patients with HIV/AIDS at Downstate Medical Center in 1985-86, Dr Bihari discovered the significant […]